Granules India US Subsidiary Receives FDA EIR with No Action Indicated Status
Published on: March 5, 2026, 11:46 a.m. | Source: scanx.trade
Granules India's US subsidiary Granules Consumer Health has received an FDA Establishment Inspection Report with No Action Indicated status following a December 2025 inspection of its Manassas, Virginia packaging facility. This marks the second consecutive clean FDA audit with zero observations, demonstrating the facility's strong regulatory compliance in processing controlled substances and OTC products across three packaging lines.
